Masaru Hayashi

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

Keiko Maeda, Takayoshi Tsutamoto, Atsuyuki Wada et al. · Journal of the American College of Cardiology · 2000 · 419 citations

Medicine, Cardiology, Internal Medicine +5

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda et al. · Journal of the American College of Cardiology · 2001 · 362 citations

Medicine, Cardiology, Pharmacology +14

Immediate Administration of Mineralocorticoid Receptor Antagonist Spironolactone Prevents Post-Infarct Left Ventricular Remodeling Associated With Suppression of a Marker of Myocardial Collagen Synthesis in Patients With First Anterior Acute Myocardial Infarction

Masaru Hayashi, Takayoshi Tsutamoto, Atsuyuki Wada et al. · Circulation · 2003 · 319 citations

Medicine, Cardiology, Pharmacology +15

Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)

Yasuyoshi Ouchi, Junichi Sasaki, Hidenori Arai et al. · Circulation · 2019 · 223 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda et al. · Journal of the American College of Cardiology · 2000 · 196 citations

Medicine, Cardiology, Pharmacology +14